Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Cigna sells Medicare business to Health Care Service for $3.3 billion

Published 01/31/2024, 07:34 AM
Updated 01/31/2024, 12:32 PM
© Reuters. FILE PHOTO: Signage for Cigna is pictured at a health facility in Queens, New York City, U.S., November 30, 2021. REUTERS/Andrew Kelly/File Photo

(Reuters) -Insurer Health Care Service Corp said on Wednesday it would buy Cigna (NYSE:CI)'s Medicare business that manages government-backed health insurance for people aged 65 and older for $3.3 billion in cash.

The sale consists of Cigna's Medicare lines, including Medicare Advantage, Medicare supplement and Medicare drug plans, as well as a unit called CareAllies that works with physician groups and other healthcare providers.

The divestiture marks a change in Cigna's strategy for the sector it had entered with its $3.8-billion acquisition of HealthSpring in 2011.

Health Care Service holds a license to provide Blue Cross Blue Shield insurance plans in five U.S. states. It employs more than 27,000 people and 18.6 million members.

The vast majority of Cigna's revenue comes from its commercial business and pharmacy benefits division, which it bolstered with the $52-billion purchase of Express Scripts in 2018.

Cigna's Medicare Advantage business generated 4.4% of the company's $179.4 billion revenue from external customers in 2022. Its plans currently serve 3.6 million Medicare members.

The deal is expected to close in early 2025, Health Care Service said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.